SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-24-000019
Filing Date
2024-08-08
Accepted
2024-08-08 08:01:11
Documents
71
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrdn-20240630.htm   iXBRL 10-Q 1486641
2 EX-10.1 exhibit101_watchfactoryvir.htm EX-10.1 108406
3 EX-31.1 ex311_2024-06.htm EX-31.1 11374
4 EX-31.2 ex312_2024-06.htm EX-31.2 12576
5 EX-32.1 ex321_2024-06.htm EX-32.1 9354
11 GRAPHIC image2a.jpg GRAPHIC 110593
12 GRAPHIC image3a.jpg GRAPHIC 90825
  Complete submission text file 0001590750-24-000019.txt   7800240

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20240630.xsd EX-101.SCH 44472
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20240630_cal.xml EX-101.CAL 59139
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20240630_def.xml EX-101.DEF 300579
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20240630_lab.xml EX-101.LAB 679278
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20240630_pre.xml EX-101.PRE 473328
74 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20240630_htm.xml XML 862574
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 241186140
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)